Administrative Core
行政核心
基本信息
- 批准号:10625687
- 负责人:
- 金额:$ 5.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-03 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAntibodiesAntigensClostridium difficileCommunitiesComplexDataEnsureFeedbackFosteringGoalsHuman ResourcesInstitutionIntellectual PropertyLeadershipLinkMonitorMucosal ImmunityNational Institute of Allergy and Infectious DiseaseNotificationProductivityReagentReportingResearchResearch PersonnelResourcesScienceTechnology TransferTravelUnited States National Institutes of HealthVaccinescommercializationenteric infectionexperienceimprovedmeetingsmemberprogramspublic databasesuccess
项目摘要
ADMINISTRATIVE CORE PROJECT SUMMARY
The Administrative Core for the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile
Vaccines (VANDy-CdV) program will serve to integrate and facilitate the broad range of activities that will be
undertaken within the program. This core will benefit from considerable administrative leadership experience
among the team members as well as strong institutional support. Four specific aims/responsibilities are
proposed. The first aim will be to coordinate program activities. The success of VANDy-CdV will depend on
frequent and meaningful interactions between all investigators. A Local Steering Committee composed of project
leaders, core directors, and key personnel will meet monthly to monitor progress, guide scientific directions, and
to monitor finance- and compliance-related issues. In addition, a full team meeting will occur quarterly to foster
productive and collaborative research. All VANDy-CdV members will be invited to share progress and solicit
constructive feedback. The Administrative Core will plan, coordinate, and document the activities from these
meetings. The second aim will be to interface with NIAID Program Officers and ensure that NIH reporting
requirements are met. In addition to official reporting requirements, the Administrative Core will notify the NIH of
all VANDy-CdV monthly and quarterly meetings. The Core will generate reports following each meeting and
distribute these reports to Local Steering Committee leaders and NIAID Program Officers. The Administrative
Core will also coordinate travel for VANDy-CdV members to attend and participate in Annual Programmatic
Meetings. The third aim is to provide fiscal oversight. Vanderbilt University Medical Center is ultimately
responsible for all spending decisions involving VANDy-CdV; however, the initial level of fiscal oversight will be
the responsibility of the Administrative Core. The fourth aim is to manage intellectual property, resource and
reagent distribution, and transmittal of data to public databases. Opportunities relating to intellectual property
across the projects and cores will be handled by the Administrative Core in conjunction with the Vanderbilt Center
for Commercialization and Technology Transfer (CTTC). The Administrative Core also will ensure that all
reasonable requests for reagents from any VANDy-CdV program are satisfied within a timely manner.
行政核心项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dana Borden Lacy其他文献
Dana Borden Lacy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dana Borden Lacy', 18)}}的其他基金
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
艰难梭菌疫苗的范德比尔特抗体和抗原发现
- 批准号:
10625686 - 财政年份:2023
- 资助金额:
$ 5.23万 - 项目类别:
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development
项目 1:粘膜毒素亚基免疫作为艰难梭菌疫苗开发的策略
- 批准号:
10625692 - 财政年份:2023
- 资助金额:
$ 5.23万 - 项目类别:
12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)
第十二届梭状芽胞杆菌分子生物学和发病机制国际会议 (Clostridia 12)
- 批准号:
10318438 - 财政年份:2021
- 资助金额:
$ 5.23万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
10412917 - 财政年份:2015
- 资助金额:
$ 5.23万 - 项目类别:
Pre-clinical evaluation of Clostridium difficile toxin inhibitors
艰难梭菌毒素抑制剂的临床前评价
- 批准号:
9487905 - 财政年份:2015
- 资助金额:
$ 5.23万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
9889242 - 财政年份:2015
- 资助金额:
$ 5.23万 - 项目类别:
The role of toxins in Clostridium difficile infection pathogenesis
毒素在艰难梭菌感染发病机制中的作用
- 批准号:
10516088 - 财政年份:2015
- 资助金额:
$ 5.23万 - 项目类别:
Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
9212765 - 财政年份:2011
- 资助金额:
$ 5.23万 - 项目类别:
Structural Mechanisms of Clostridioides difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
10620653 - 财政年份:2011
- 资助金额:
$ 5.23万 - 项目类别:
Structural mechanisms of Clostridium difficile pathogenesis
艰难梭菌发病机制的结构机制
- 批准号:
9916698 - 财政年份:2011
- 资助金额:
$ 5.23万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 5.23万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 5.23万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 5.23万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 5.23万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 5.23万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 5.23万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 5.23万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 5.23万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 5.23万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 5.23万 - 项目类别:
Standard Grant














{{item.name}}会员




